Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Verséa Biologics is a regenerative medicine company and a specialized division of Verséa Health, focused on the distribution and clinical application of human birth tissue-derived biologics. The company provides advanced solutions for wound care, ophthalmology, and orthopedics, primarily through its partnership with Celularity to distribute products like BIOVANCE and Interfyl. These products utilize decellularized human amniotic membrane and connective tissue matrices to provide a natural scaffold for tissue repair and regeneration. Verséa Biologics aims to improve patient outcomes in complex surgical and chronic wound environments by leveraging the innate healing properties of placental-derived tissues. The company operates as a key commercial bridge between advanced biotechnology manufacturing and healthcare providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Verséa Biologics.